Literature DB >> 2885256

Detection of submicroscopic deletions and a DNA polymorphism at the retinoblastoma locus.

B Horsthemke, V Greger, H J Barnert, W Höpping, E Passarge.   

Abstract

DNA samples from 60 unrelated patients with retinoblastoma were screened by Southern blot hybridization using two probes that are closely linked to the retinoblastoma locus within human chromosome band 13q14. Seven of 44 patients with bilateral or multifocal unilateral retinoblastoma and one patient with unifocal unilateral retinoblastoma were found to have a heterozygous deletion for the anonymous DNA sequence H3-8. Three of the eight deletions did not include the esterase D locus and were undetectable by conventional cytogenetic analysis. The findings are compatible with the deletions being the cause of retinoblastoma in these cases and provide a basis for DNA diagnosis in nearly 20% of patients with bilateral and multifocal unilateral retinoblastoma. The H3-8 probe also detects a restriction fragment length polymorphism that is a useful genetic marker in some families.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885256     DOI: 10.1007/bf00283619

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

Review 2.  DNA polymorphism and molecular pathology of the human globin gene clusters.

Authors:  S E Antonarakis; H H Kazazian; S H Orkin
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13.

Authors:  W Cavenee; R Leach; T Mohandas; P Pearson; R White
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

5.  Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14.

Authors:  R S Sparkes; M C Sparkes; M G Wilson; J W Towner; W Benedict; A L Murphree; J J Yunis
Journal:  Science       Date:  1980-05-30       Impact factor: 47.728

6.  Homozygosity of chromosome 13 in retinoblastoma.

Authors:  T P Dryja; W Cavenee; R White; J M Rapaport; R Petersen; D M Albert; G A Bruns
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

7.  Cloning of the esterase D gene: a polymorphic gene probe closely linked to the retinoblastoma locus on chromosome 13.

Authors:  J Squire; T P Dryja; J Dunn; A Goddard; T Hofmann; M Musarella; H F Willard; A J Becker; B L Gallie; R A Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus.

Authors:  M Lalande; T P Dryja; R R Schreck; J Shipley; A Flint; S A Latt
Journal:  Cancer Genet Cytogenet       Date:  1984-12

10.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  13 in total

1.  Constitutional deletions predisposing to retinoblastoma.

Authors:  M Janson; E Kock; M Nordenskjöld
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

2.  Maternal origin of a de novo chromosome 8 deletion in a patient with Langer-Giedion syndrome.

Authors:  H J Lüdecke; R Burdiek; G Senger; U Claussen; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

3.  Types, rates, origin and expressivity of chromosome mutations involving 13q14 in retinoblastoma patients.

Authors:  Y Ejima; M S Sasaki; A Kaneko; H Tanooka
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

4.  Construction and characterization of band-specific DNA libraries.

Authors:  H J Lüdecke; G Senger; U Claussen; B Horsthemke
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

5.  Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma.

Authors:  V Greger; E Passarge; W Höpping; E Messmer; B Horsthemke
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

6.  An association of the RB gene with osteosarcoma: molecular genetic evaluation of a case of hereditary retinoblastoma.

Authors:  W J Issing; T P Wustrow; R Oeckler; J Mezger; A Nerlich
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Application of linkage analysis to genetic counselling in families with hereditary retinoblastoma.

Authors:  V Greger; S Kerst; E Messmer; W Höpping; E Passarge; B Horsthemke
Journal:  J Med Genet       Date:  1988-04       Impact factor: 6.318

8.  Excess of multifocal tumors in nephroblastoma: implications for mechanisms of tumor development and genetic counseling.

Authors:  C Bonaïti-Pellié; A Chompret; M F Tournade; J Lemerle; P A Voute; J F Delemarre
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

9.  Molecular detection of genetic defects in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a study of 27 families.

Authors:  D Strumberg; B P Hauffa; B Horsthemke; H Grosse-Wilde
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

10.  Somatic mosaicism in a patient with bilateral retinoblastoma.

Authors:  V Greger; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.